Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Sotio Biotech Inc.
Pfizer
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Bolt Biotherapeutics, Inc.
Shasqi, Inc.
Incyte Corporation
Actym Therapeutics, Inc.
Pfizer
Pfizer
Numab Therapeutics AG
Elevation Oncology
Seagen Inc.
Aminex Therapeutics, Inc.
NantCell, Inc.
Pfizer
ABM Therapeutics Corporation
Pfizer
CytomX Therapeutics
Atreca, Inc.
Fusion Pharmaceuticals Inc.
Fate Therapeutics
Hoffmann-La Roche
MacroGenics
Incyte Corporation
Seagen Inc.
Daiichi Sankyo
Tocagen Inc.
CureOne
Otsuka Novel Products GmbH
Calando Pharmaceuticals
Vanderbilt-Ingram Cancer Center